Chemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancer

Pathology Research and Practice

Volumn 210, Issue 2, 2014, Pages 74-78

  Miyake, Makito ^a   Lawton, Adrienne ^a   Goodison, Steve ^a,b   Urquidi, Virginia ^a   Rosser, Charles J ^a,b  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b Nonagen Bioscience Corp   (United States)

Author keywords

Cancer; Chemokine (C X C motif) ligand 1 (CXCL1); Grade; Prostate; Stage

Indexed keywords

CXCL1 CHEMOKINE; CXCL1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CYTOPLASM; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE MICROARRAY; VERY ELDERLY; ANIMAL; ANTIBODY SPECIFICITY; COHORT ANALYSIS; EPITHELIUM; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROTEOMICS; TUMOR CELL LINE; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; CHEMOKINE CXCL1; COHORT STUDIES; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATIC NEOPLASMS; PROTEOMICS; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 84892863344     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.08.013     Document Type: Article

References (20)

1. Sakai Y., Goodison S., Kusmartsev S., Fletcher B., Eruslanov E., Cao W., Porvasnik S., Namiki K., Anai S., Rosser C.J. Bcl-2 mediated modulation of vascularization in prostate cancer xenografts. Prostate 2008.
2. Sakai Y., Goodison S., Cao W., Urquidi V., Namiki K., Porvasnik S., Urbanek C., Rosser C.J. VEGF induces expression of Bcl-2 and multiple signaling factors in microvascular endothelial cells in a prostate cancer model. World J. Urol. 2009.
3. Raghuwanshi S.K., Su Y., Singh V., Haynes K., Richmond A., Richardson R.M. The chemokine receptors CXCR1 and CXCR2 couple to distinct g protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol. 2012, 189(6):2824-2832.
4. Su Y., Raghuwanshi S.K., Yu Y., Nanney L.B., Richardson R.M., Richmond A. Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models. J. Immunol. 2005, 175(8):5396-5402.
5. Engl T., Relja B., Blumenberg C., Müller I., Ringel E.M., Beecken W.D., Jonas D., Blaheta R.A. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix. Life Sci. 2006, 78(16):1784-1793.
6. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62(1):10-29.
7. Nelson W.G., et al. Prostate cancer. N. Engl. J. Med. 2003, 349:366-381.
8. Wallace T.A., Prueitt R.L., Yi M., Howe T.M., Gillespie J.W., Yfantis H.G., Stephens R.M., Caporaso N.E., Loffredo C.A., Ambs S. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008 Feb 1, 68(3):927-936.
9. Hembruff S.L., Cheng N. Chemokine signaling in cancer: implications on the tumor microenvironment and therapeutic targeting. Cancer Ther. 2009, 7(A):254-267.
10. Hannelien V., Karel G., Jo V.D., Sofie S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim. Biophys. Acta. 2012, 1825(1):117-129.
11. Moll N.M., Cossoy M.B., Fisher E., Staugaitis S.M., Tucky B.H., Rietsch A.M., Chang A., Fox R.J., Trapp B.D., Ransohoff R.M. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch. Neurol. 2009, 66(1):44-53.
12. Gillitzer R., Goebeler M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 2001, 69(4):513-521.
13. Matsushima K., Baldwin E.T., Mukaida N. Interleukin-8 and MDAF: novel leukocyte recruitment and activity cytokines. Chem. Immunol. 1992, 51:236-265.
14. Koch A.E., Polverini P.S., Kunkel S.L., Harlow L.A., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
15. Wang J.M., Taraboletti G., Matsushima K., Samme J.V., Mantovani A. Induction of hepatotactic migration of melanoma cells by neutrophil activating protein/IL-8. Biochem. Biophys. Res. Commun. 1990, 169:165-170.
16. Strieter R.M., Kunkel S.L., Elner V.M., Martonyi C.L., Koch A.E., Polverini P.J., Elner S.G. Interleukin-8: a corneal factor that induces neovascularization. Am. J. Pathol. 1992, 141:1270-1284.
17. Luan J., Shattuck-Brandt R., Haghnegahdar H., Owen J.D., Strieter R., Burdick M., Nirodi C., Beauchamp D., Johnson K.N., Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 1997 Nov, 62(5):588-597.
18. Verbeke H., Struyf S., Laureys G., Van Damme J. The expression and role of CXC chemokines in colorectal cancer. Cytokine Growth Factor Rev. 2011, 22(5-6):345-358.
19. Dhawan P., Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 2002, 72(1):9-18.
20. Baird A.M., Gray S.G., O'Byrne K.J. Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer. PLoS ONE 2011, 6(1.).